Current Research Studies

A Randomized, Open-Label, Acitve Controlled, Safety and Extrapolated Efficacy Study in Pediatric Subjects Requiring Anticoagulation for the Treatment of a Venous Thromboembolic Event

Apixaban

Phase: IV
Clinicaltrials.gov ID: NCT02464969

What is the goal of the study?

A Randomized, Open-Label, Active Controlled, Safety and Extrapolated Efficacy Study in Pediatric Subjects Requiring Anticoagulation for the Treatment of a Venous Thromboembolic Event

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Agustin Rubio
Study Team Member: Jeremy Gillis, [email protected]